Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Using Modular Systems in Biopharmaceutical Manufacturing

May 15, 2014

What is a modular system and how are modular systems being used in the biopharmaceutical industry? Pär

Single-Use Technology in Parenteral Fill/Finish

May 15, 2014

Application of single-use technology in a parenteral facility for syringe filling.

Continuous Manufacturing in Solid-Dosage Drug Production, an Interview with Doug Hausner, C-SOPS

May 14, 2014

An interview with Doug Hausner, C-SOPS, about continuous manufacturing

FDA Releases Draft Guidance on Biosimilarity

May 14, 2014

Draft guidance addresses the use of clinical pharmacology studies to determine biosimilarity of biologics.

Advanced Aseptic Technology Provides Glass-Free Delivery of Injectable Drugs

May 14, 2014

Equipment and Processing Report

Catalent's Advasept platform uses blow-fill-seal technology to aseptically manufacture, fill, and seal a polymeric primary container for injectable drugs.

ionHP Biodecontamination Technology for Aseptic Systems

May 12, 2014

The ionHP biodecontamination hydrogen peroxide-based sterilization technology is designed for use in aseptic enclosures.

Tablet Press Increases Output

May 08, 2014

The Manesty TPR 500 tablet press from Bosch Packaging Technology increases output and features a hygienic design.

Demand for New Vaccines Spurs Innovation

May 02, 2014

New formulations and expanded vaccine production are encouraged.

Gallus BioPharmaceuticals Enters Agreement with Omni Bio Pharmaceutical

May 01, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.

Gallus BioPharmaceuticals Uses ambr15 Micro Bioreactor to Develop Novel Antibodies and Biosimilars

April 30, 2014

TAP Biosystems announced that Gallus BioPharmaceuticals is using its ambr15 micro bioreactor system to optimize process development and clone selection of novel antibody therapeutics and biosimilars.